Abstract 442: Dual KAT6/7 inhibition disrupts epigenetic programs that promote tumor evolution and adaptive drug resistance

Authors: Manav Gupta, Pranav Gupta, Scott R. Tyler, Nour Ghaddar, Steven L. Spivak, Zabrisky Roland, Katelyn N. Lukas, Ivan G. Shabalin, Jonathon S. Ryan, Carl Schultz, Daniel M. Walden, Santosh Keshipeddy, Muzaffar Alam, Daniel Severance, Anjali Bisaria, Kelly S. Tego, Parker Y. Jameson, Mason J. Appel, Brittany Cruzan, Jay Prakash Jain, Michael E. Dalziel, Sunjay Sethi, Rebeca Choy, Richard Zang, Xin Linghu, Yuchen Bai, Peter Teriete, Diana M. Muñoz, Christian R. Frey, Claire L. Neilan, Josh Taygerly, Jacob Burch-Konda, Paul A. Barsanti, Michael A. White, Brian T. Jones

Published: 2025-04-22

DOI: 10.1158/1538-7445.am2025-442

Source: Full article


Abstract

Abstract